Statin Therapy Considerations for Elderly Patients

Age-Based Considerations

The American College of Cardiology recommends that for adults over 75 years of age, it is reasonable to stop statin therapy when functional decline, multimorbidity, frailty, or reduced life expectancy limits the potential benefits 1
For patients over 75 years without established cardiovascular disease, the benefit-risk ratio of statin therapy becomes less favorable with advancing age 1, 2

Drug interactions become more concerning due to likely polypharmacy at this age 2
The American College of Cardiology suggests that an LDL level of 103 mg/dL is only mildly elevated and does not meet the threshold for mandatory treatment 3
The American College of Cardiology recommends that for patients with mildly elevated LDL, such as 103 mg/dL, statin therapy may not be warranted in the absence of established cardiovascular disease at this advanced age 1

The American College of Cardiology suggests that if a patient has documented coronary artery disease, prior stroke, or peripheral arterial disease, moderate-intensity statin therapy could be considered 2
The American College of Cardiology recommends that if significant functional decline, frailty, or limited life expectancy is present, avoid starting statin therapy 1
The American College of Cardiology suggests that with an LDL level of 103 mg/dL and no hypertension, the patient does not have compelling indications for statin therapy 3, 1

The American College of Cardiology recommends that if the patient has documented atherosclerotic cardiovascular disease (ASCVD), the recommendation would change to favor moderate-intensity statin therapy 2
The American College of Cardiology suggests that if the patient is already on a statin and tolerating it well without side effects, it may be reasonable to continue therapy 1
The American College of Cardiology recommends avoiding high-intensity statin therapy in this age group due to increased risk of adverse effects 1